From: Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
# of grade 4 toxicity events
Upper limits of one-sided 95% confidence interval for true rate of grade 4 toxicities (sample size = 200)
0
1.5%
1
2.3%
2
3.1%
3
3.8%
4
4.5%
5
5.2%
6
5.8%